Scientists developing selenium-enriched tea have identified a powerful selenium-reducing bacterium, Raoultella ornithinolytica S-1, capable of converting inorganic selenium into selenium nanoparticles (SeNPs) while simultaneously promoting plant growth.
Premature yeast flocculation (PYF) is a persistent issue in beer brewing, where yeast settles too early during fermentation. New research identifies multiple differential metabolites and confirmed galangin as a key factor that promotes early yeast aggregation.
A new study has found that the levels of antimicrobial resistance (AMR) present in surface water increase during winter. Flooding, sewer overflows and agricultural run-off all contribute to a cocktail of pollutants that can increase AMR genes in surface water, potentially turning regular bugs into ‘superbugs’.
A new paper outlines how scientists came together to put together the first microbial conservation roadmap under the leadership of Applied Microbiology International President, Professor Jack Gilbert.
Researchers have discovered a novel way to fuse lipid vesicles at neutral pH. By harnessing a fragment of the diphtheria toxin, the team achieved vesicle membrane fusion without the need for pre-treatment or harsh conditions, opening the door to new applications.
A new paper outlines how scientists came together to put together the first microbial conservation roadmap under the leadership of Applied Microbiology International President, Professor Jack Gilbert.
Scientists developing selenium-enriched tea have identified a powerful selenium-reducing bacterium, Raoultella ornithinolytica S-1, capable of converting inorganic selenium into selenium nanoparticles (SeNPs) while simultaneously promoting plant growth.
Premature yeast flocculation (PYF) is a persistent issue in beer brewing, where yeast settles too early during fermentation. New research identifies multiple differential metabolites and confirmed galangin as a key factor that promotes early yeast aggregation.
A new study has found that the levels of antimicrobial resistance (AMR) present in surface water increase during winter. Flooding, sewer overflows and agricultural run-off all contribute to a cocktail of pollutants that can increase AMR genes in surface water, potentially turning regular bugs into ‘superbugs’.
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
Researchers have discovered a novel way to fuse lipid vesicles at neutral pH. By harnessing a fragment of the diphtheria toxin, the team achieved vesicle membrane fusion without the need for pre-treatment or harsh conditions, opening the door to new applications.
The team engineered Komagataeibacter xylinus for bacterial cellulose synthesis and Escherichia coli for natural colorant overproduction. A co-culture of these engineered strains enabled the in situ coloration of bacterial cellulose.
Scientists have developed an automated, high-throughput system that relies on imaging droplets of biofluids for disease diagnosis in an attempt to reduce the number of consumables and equipment needed for biomedical testing.
A new paper outlines how scientists came together to put together the first microbial conservation roadmap under the leadership of Applied Microbiology International President, Professor Jack Gilbert.
GSK and the Fleming Initiative have announced six major new research programmes, called ‘Grand Challenges’ which harness some of the best scientific expertise and the latest technologies, including advanced AI, to find new ways to slow the progress of antimicrobial resistance (AMR).
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.